Caribou Biosciences, Inc.
CRBU
$1.98
$0.1015.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.07% | -28.29% | -46.08% | -56.65% | -11.01% |
| Total Depreciation and Amortization | 20.80% | 20.19% | 11.40% | 5.83% | 79.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.59% | -22.50% | -3.82% | 140.76% | 49.46% |
| Change in Net Operating Assets | 46.33% | 0.76% | 30.12% | 133.78% | -269.06% |
| Cash from Operations | -10.71% | -34.29% | -48.14% | -28.01% | -32.79% |
| Capital Expenditure | 75.27% | 59.44% | 57.98% | 40.15% | -39.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 362.90% | 314.01% | 261.70% | 287.52% | -239.58% |
| Cash from Investing | 307.67% | 271.44% | 227.02% | 210.31% | -326.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.90% | -97.15% | -89.16% | -91.67% | 638.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.90% | -97.15% | -89.16% | -91.70% | 638.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.29% | -497.58% | -385.91% | -428.08% | 38.35% |